O. N. Kichigina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
O. N. Kichigina has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Evgenia Aleksandrovna Kogan
I.M. Sechenov First Moscow State Medical University (Sechenov University)
3 shared publications - Nikolay Vladimirovich Zharkov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Tat'YAna Aleksandrovna Demura
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - A. D. Kukleva
Institute for Clinical Morphology and Digital Pathology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya St., 8/2, 119048 Moscow, Russia
1 shared publication - A. I. Mordovina
Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication A. Zachariah
I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University), Moscow
1 shared publication
Latest Publications
- 27 January 2026
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 88 (1) , 52-59
Pathology of the digestive system organs in post-COVID syndrome according to autopsy data from 2021—2024
Objective. Clinical and morphologic analysis of pathologic changes of digestive system organs in COVID-19 patients according to autopsy data of 2021—2024. Material and methods. A retrospective clinical and morphologic analysis of data from 69 autopsies of patients who underwent COVID-19 (confirmed by polymerase chain reaction test) and had symptoms of digestive system lesions, according to clinical data, was performed. The data of case histories, autopsies, pathologoanatomic diagnoses and causes of death of patients were studied. Microscopic studies of tissue samples of stomach, intestine, liver, pancreas were performed. Immunohistochemical study with antibodies CD3, CD45, CD68, spike- and nucleocapsid-protein SARS-CoV-2 was performed. Results. According to autopsy data, pathologic changes of the stomach that first developed and pre-existing more than 3 months after SARS-CoV-2 infection were detected in 49 (71.01%) of 69 cases. Among them, chronic superficial gastritis was the most common with 17 (34.99%) observations and acute stress-induced gastric erosions and ulcers with 13 (26.53%). Small and large intestinal lesions were seen in 15 (30.61%) cases, among which intestinal adenocarcinomas predominated with 6 (40.00%), colonic diverticula and chronic lymphocytic colitis with 3 (20.00%) cases each. Liver pathology, new-onset and pre-existing, was present in 100.00% cases: muscadic liver 45 (65.22%), massive liver necrosis (7.25%), hepatic steatosis and steatohepatitis (26.09%), brown atrophy (8.70%). Pancreatic lesions, new-onset and pre-existing, were detected in 57 (82.60%) cases. Among them, sclerosis and lipomatosis were more frequently registered in type 2 diabetes mellitus — 46 (80.70%) observations, pancreonecrosis — 11 (19.30%). Conclusions. Gastric, intestinal, liver, and pancreatic pathology in COVID-19 patients may be either first-onset or preexisting. The detected persistence of nucleocapsid and spike proteins of the virus in tissues may cause direct and autoimmune tissue damage, leading to the development of new and progressive chronic diseases of the digestive organs.
- 27 January 2026
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 88 (1) , 52-59
Pathology of the digestive system organs in post-COVID syndrome according to autopsy data from 2021—2024
Objective. Clinical and morphologic analysis of pathologic changes of digestive system organs in COVID-19 patients according to autopsy data of 2021—2024. Material and methods. A retrospective clinical and morphologic analysis of data from 69 autopsies of patients who underwent COVID-19 (confirmed by polymerase chain reaction test) and had symptoms of digestive system lesions, according to clinical data, was performed. The data of case histories, autopsies, pathologoanatomic diagnoses and causes of death of patients were studied. Microscopic studies of tissue samples of stomach, intestine, liver, pancreas were performed. Immunohistochemical study with antibodies CD3, CD45, CD68, spike- and nucleocapsid-protein SARS-CoV-2 was performed. Results. According to autopsy data, pathologic changes of the stomach that first developed and pre-existing more than 3 months after SARS-CoV-2 infection were detected in 49 (71.01%) of 69 cases. Among them, chronic superficial gastritis was the most common with 17 (34.99%) observations and acute stress-induced gastric erosions and ulcers with 13 (26.53%). Small and large intestinal lesions were seen in 15 (30.61%) cases, among which intestinal adenocarcinomas predominated with 6 (40.00%), colonic diverticula and chronic lymphocytic colitis with 3 (20.00%) cases each. Liver pathology, new-onset and pre-existing, was present in 100.00% cases: muscadic liver 45 (65.22%), massive liver necrosis (7.25%), hepatic steatosis and steatohepatitis (26.09%), brown atrophy (8.70%). Pancreatic lesions, new-onset and pre-existing, were detected in 57 (82.60%) cases. Among them, sclerosis and lipomatosis were more frequently registered in type 2 diabetes mellitus — 46 (80.70%) observations, pancreonecrosis — 11 (19.30%). Conclusions. Gastric, intestinal, liver, and pancreatic pathology in COVID-19 patients may be either first-onset or preexisting. The detected persistence of nucleocapsid and spike proteins of the virus in tissues may cause direct and autoimmune tissue damage, leading to the development of new and progressive chronic diseases of the digestive organs.
- 1 January 2025
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 13 (4)
Effects of lung pathology in post COVID-19
- 1 January 2025
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 13 (4)
Effects of lung pathology in post COVID-19
- 22 October 2024
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 86 (5) , 5-14
ALDH1, CD133, CD34-positive cancer stem cells in lung adenocarcinoma in patients who had a new coronavirus infection and retained the persistence of viral proteins in the lung tissue
Lung cancer occupies a leading position in the structure of global cancer morbidity and mortality, due to the biological properties of the key pool of tumor cells — cancer stem cells (CSCs). The effects of SARS-CoV2 on tumor CSCs and its niche have not been studied. Objective. To study CSCs in lung adenocarcinomas after COVID19. Material and methods. Surgical material from lung adenocarcinoma from 12 patients who had a new coronavirus infection and from 12 patients who did not have COVID19 was examined. Analysis of clinical and anamnestic data, macroscopic and microscopic examination of tumor samples and adjacent intact tissue, immunohistochemical reactions using antibodies to virus proteins and CSC markers ALDH1, CD133 and CD34 were performed. Results. Adenocarcinoma samples from patients in the main group showed a significant increase in the number of cells expressing the CSCs markers ALDH1, CD133 and CD34 compared to adenocarcinoma samples from control group patients without SARS-CoV2 infection. We found an increase in the number of CSCs in patients with adenocarcinoma metastasis in lymph nodes in both the main and control groups. CSCs of lung adenocarcinomas from SARS-CoV2 survivors contain virus proteins Nucleocapside and Spike protein. Conclusions. We found an increase in the number of CSCs with expression of ALDH1, CD133 and CD34 in lung adenocarcinoma in patients with new coronavirus infection. Increased number of ALDH1+, CD133+ CD34+ CSCs in tumor tissue enhance the metastatic potential of lung adenocarcinoma. The Nucleocapsid and Spike proteins of SARS-CoV2 virus are detectable in lung tissue from patients with new coronavirus infection, both in adenocarcinoma cells, CSCs, and in type II pneumocytes, macrophages, and endothelial cells, suggesting prolonged persistence of the virus proteins and probably the virus.
- 22 October 2024
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 86 (5) , 5-14
ALDH1, CD133, CD34-positive cancer stem cells in lung adenocarcinoma in patients who had a new coronavirus infection and retained the persistence of viral proteins in the lung tissue
Lung cancer occupies a leading position in the structure of global cancer morbidity and mortality, due to the biological properties of the key pool of tumor cells — cancer stem cells (CSCs). The effects of SARS-CoV2 on tumor CSCs and its niche have not been studied. Objective. To study CSCs in lung adenocarcinomas after COVID19. Material and methods. Surgical material from lung adenocarcinoma from 12 patients who had a new coronavirus infection and from 12 patients who did not have COVID19 was examined. Analysis of clinical and anamnestic data, macroscopic and microscopic examination of tumor samples and adjacent intact tissue, immunohistochemical reactions using antibodies to virus proteins and CSC markers ALDH1, CD133 and CD34 were performed. Results. Adenocarcinoma samples from patients in the main group showed a significant increase in the number of cells expressing the CSCs markers ALDH1, CD133 and CD34 compared to adenocarcinoma samples from control group patients without SARS-CoV2 infection. We found an increase in the number of CSCs in patients with adenocarcinoma metastasis in lymph nodes in both the main and control groups. CSCs of lung adenocarcinomas from SARS-CoV2 survivors contain virus proteins Nucleocapside and Spike protein. Conclusions. We found an increase in the number of CSCs with expression of ALDH1, CD133 and CD34 in lung adenocarcinoma in patients with new coronavirus infection. Increased number of ALDH1+, CD133+ CD34+ CSCs in tumor tissue enhance the metastatic potential of lung adenocarcinoma. The Nucleocapsid and Spike proteins of SARS-CoV2 virus are detectable in lung tissue from patients with new coronavirus infection, both in adenocarcinoma cells, CSCs, and in type II pneumocytes, macrophages, and endothelial cells, suggesting prolonged persistence of the virus proteins and probably the virus.
- 1 January 2024
- Published by Yaroslav-the-Wise Novgorod State University in Vestnik NovSU
- No. 4
Morphological manifestations of lung pathology in postcovid syndrome according to the results of autopsies for the period 2021-2023
The problem of postcovid syndrome is relevant due to the high incidence of COVID-19, as well as the lack of awareness of medical professionals about its consequences, the pathogenesis of postcovid syndrome remains controversial and requires further research. The aim of the study was to determine the morphological manifestations of lung pathology in postcovid syndrome in 2021-2023 based on the study of autopsy material. After analyzing retrospective morphological studies of 34 autopsy cases diagnosed with postcovid syndrome, it was revealed that among the changes in lung tissue, chronic obstructive pulmonary disease (71%), common interstitial pneumonia (44%), bronchopneumonia (26%) and nonspecific interstitial pneumonia (24%) were the predominant processes. Hemorrhagic heart attacks also attracted attention (9%). Hypersensitivity pneumonitis, sarcoidosis and adenocarcinoma were more rare (3% each). It is worth noting that in almost all cases, there were phenomena of vasculitis, fullness and thrombosis of small vessels in the surrounding lung tissue.
- 1 January 2024
- Published by Yaroslav-the-Wise Novgorod State University in Vestnik NovSU
- No. 4
Morphological manifestations of lung pathology in postcovid syndrome according to the results of autopsies for the period 2021-2023
The problem of postcovid syndrome is relevant due to the high incidence of COVID-19, as well as the lack of awareness of medical professionals about its consequences, the pathogenesis of postcovid syndrome remains controversial and requires further research. The aim of the study was to determine the morphological manifestations of lung pathology in postcovid syndrome in 2021-2023 based on the study of autopsy material. After analyzing retrospective morphological studies of 34 autopsy cases diagnosed with postcovid syndrome, it was revealed that among the changes in lung tissue, chronic obstructive pulmonary disease (71%), common interstitial pneumonia (44%), bronchopneumonia (26%) and nonspecific interstitial pneumonia (24%) were the predominant processes. Hemorrhagic heart attacks also attracted attention (9%). Hypersensitivity pneumonitis, sarcoidosis and adenocarcinoma were more rare (3% each). It is worth noting that in almost all cases, there were phenomena of vasculitis, fullness and thrombosis of small vessels in the surrounding lung tissue.